Is the Depo Brain Tumor Lawsuit Still Active?

Yes, the Depo-Provera brain tumor lawsuit is still active, with new claims continuously joining a federal multidistrict litigation (MDL). These lawsuits claim that Depo-Provera increases the risk of meningioma brain tumors, particularly with long-term use. With growing awareness of the connection between Depo-Provera and meningioma brain tumors, more women who have faced related health issues are now pursuing legal claims.

At Uptown Injury Law, PLLC, we’ve been closely involved in the Depo-Provera lawsuit, fighting for victims like you. Our team knows how to position your claim in this active case and demand justice. We understand the unique medical and legal challenges of these lawsuits and work to secure the compensation you deserve. Reach out now at 917-540-8728 for a free case review.

What Are the Latest Updates on the Depo Brain Tumor Lawsuit?

The latest update on the Depo-Provera brain tumor lawsuit confirms 348 active cases as of June 1, 2025. Currently, these cases are part of the Depo-Provera multidistrict litigation (MDL), overseen by the Judicial Panel on Multidistrict Litigation. This JPML process combines these cases to speed up proceedings and ensure fair, consistent rulings.

On June 13, 2025, a woman in Indiana filed a Depo-Provera lawsuit, claiming decades of using this birth control had caused her multiple brain tumors. Her case was immediately transferred to the MDL, joining growing legal action against Pfizer.

Moreover, an important court hearing is scheduled in the Depo-Provera MDL in the next four months. Pfizer plans to argue that it shouldn’t be held responsible because the FDA approved the drug’s label. Consequently, the decision from that hearing could directly impact the direction and outcome of many other Depo-Provera lawsuits.

Who Can Join the Depo Provera Brain Tumor Lawsuit?

If you’ve developed a meningioma brain tumor after taking Depo-Provera, Depo-SubQ Provera, or an approved generic, you may qualify for a lawsuit. Typically, eligibility depends on your Depo-Provera use history, diagnosis details, and medical records.

Here are the key factors that can help determine if you are eligible for a Depo-Provera lawsuit:

RequirementDetails
Depo-Provera UseBrand Name: Depo-Provera or approved generic version
Minimum InjectionsAt least two doses
DiagnosisMeningioma brain tumor
Proof NeededMedical records linking the tumor to use
Use Duration12 months or more (preferred)

Determining your eligibility for a Depo-Provera brain tumor lawsuit can be complex. That’s why our experienced Depo-Provera attorneys review your records, assess eligibility, and explain your legal options clearly before you take the next step. Contact us today for a free case review and get the legal support you deserve.

How Does Depo Provera Lead to Brain Tumors?

Use of Depo-Provera can increase your risk of brain tumors by affecting how brain cells grow. Specifically, its active ingredient, medroxyprogesterone acetate, is a man-made version of the hormone progesterone. In your body, progesterone controls the growth of certain cells, including those in the brain and spinal cord.

This hormone attaches to progesterone receptors in the brain’s protective layers. When these receptors are repeatedly exposed to medroxyprogesterone acetate, especially with long-term or frequent use, they can trigger abnormal cell growth. Over time, these changes may lead to meningiomas, a type of brain tumor that forms in the tissues surrounding the brain.

What Is the Average Payout for a Meningioma Brain Tumor Lawsuit?

The average payout for a meningioma brain tumor lawsuit usually ranges from $150,000 to $500,000. In some Depo-Provera cases, settlements have reached over $2 million when serious health problems and financial losses were proven. However, your final settlement depends on factors like tumor severity, long-term medical needs, and how strongly your case links Depo-Provera to your diagnosis. When you pursue a Depo-Provera lawsuit, your compensation may include:

  • Surgery and medical treatment costs
  • Lost wages and reduced earning ability
  • Ongoing care and rehabilitation expenses
  • Compensation for emotional suffering and mental distress
  • Punitive damages if Pfizer’s failure to warn about tumor risks is proven

Additionally, most Depo-Provera settlements are negotiated directly. If no agreement is made, your brain tumor lawsuit may proceed to trial. In 2021,a Depo Provera class actionover risks like bone density loss resulted in multi-million-dollar payouts. This legal history shows Pfizer has faced costly settlements before, adding weight to the potential value of the current Provera brain tumor lawsuit claims.

How Can You Prove the Link Between Depo-Provera and Brain Tumors?

You can prove the link between Depo-Provera and brain tumors by combining medical records, expert testimony, diagnostic imaging, and scientific research. Additionally, the strength of your Depo-Provera brain tumor case depends on clear, organized evidence. To build a strong case, consider following these key steps:

1. Document Your Depo-Provera Use

Start by collecting detailed records confirming your Depo-Provera use before your diagnosis. These include injection dates, dose amounts, and doctor visit notes. This information shows your history with the drug and supports your claim that it came before you developed brain tumors.

2. Secure Diagnostic Imaging Reports

Next, gather any CT or MRI scans showing your tumor’s location, size, and type. These reports confirm you’re dealing with a meningioma, which matters in Depo-Provera cases. Imaging also helps medical experts link tumor growth patterns to progesterone exposure timelines.

3. Find Reliable Medical Studies

Find a trusted research study linking Depo-Provera use to meningioma risk. Focus especially on studies explaining how prolonged exposure raises the risk of these tumors. A 2024 BMJ study found that women using Depo-Provera for one year or more had a 5.6 times higher risk of developing meningioma, while short-term use showed no increased risk. The study confirmed that prolonged exposure raises tumor risk by affecting hormone-sensitive brain tissue. Including this evidence will strengthen your case and help prove the connection.

4. Hire Medical Experts

Contact experienced medical specialists familiar with Depo-Provera brain tumor cases. These experts explain how the drug affects brain tissues and why your tumor likely developed from it. Therefore, their testimony helps the court connect your diagnosis to your Depo-Provera use.

At Uptown Injury Law, PLLC, our experienced attorneys work with medical specialists to gather expert testimony, records, and trusted research for your claim. Contact us now at 917-540-8728 and let our team build your case.

What Are the Legal Defenses Pfizer Is Using in the Depo Provera Lawsuit?

Pfizer defends itself in Depo-Provera shot lawsuits by denying legal responsibility for brain tumor risks. Pfizer argues it followed all regulatory requirements and, therefore, isn’t liable for patient injuries. Here are the main legal defenses Pfizer uses in these cases.

Claiming Insufficient Evidence

Pfizer claims existing research doesn’t clearly prove Depo-Provera causes brain tumors. Moreover, the company argues that no reliable study confirms a definite link. This defense allows manufacturers to challenge responsibility for brain tumor claims in both individual cases and Depo-Provera class action lawsuits.

Defending Safe Use Under FDA Guidelines

Depo-Provera manufacturers argue the drug remains safe when used as prescribed. Furthermore, Pfizer claims it followed FDA-approved Depo-Provera labeling and instructions. By following these federal rules, the company believes it isn’t responsible for injuries from Depo-Provera or generic Depo-Provera.

Using Federal Law to Block State Claims

Pfizer says federal law overrules state failure-to-warn claims in Depo-Provera shot lawsuits. Moreover, the company claims the FDA rejected a proposed tumor warning label. For this reason, Pfizer believes it can’t be sued for following agency decisions on drug safety.

However, these legal defenses don’t automatically prevent you from seeking compensation. Our Depo-Provera lawsuit attorneys know how to challenge preemption defenses and corporate claims. Contact our Depo Provera lawsuit lawyer now to schedule your free consultation.

What Are the Common Misconceptions About the Depo Provera Lawsuit?

The most common misconception among the users of this injectable birth control is that these lawsuits are class actions. However, in reality, each case is handled separately based on your injuries. It’s also important to know that you don’t need life-threatening symptoms to file a claim. Even moderate health issues from the injectable contraceptive Depo-Provera may qualify you for legal action.

Another widespread myth is that every case results in a guaranteed payout. However, the truth is, you must prove the Depo-Provera birth control shot caused your tumor or related symptoms. Many believe FDA approval protects Depo-Provera manufacturers, but it doesn’t. In fact, companies remain liable for undisclosed health risks like brain tumors.

Let Uptown Injury Law Fight for Justice in Your Depo-Provera Brain Tumor Case — Get a Free Case Review!

If you’re a Depo-Provera user and have developed a meningioma brain tumor, it means you were not properly informed about the potential risks associated with this medication. That dishonesty leaves you facing difficult decisions about your health, your future, and who you can rely on for answers. When drugmakers fail to warn you about the serious health dangers of their drug, they must be held accountable for the harm they’ve caused.

At Uptown Injury Law, PLLC, we’ve built a proven record handling Depo-Provera lawsuits and standing up for people harmed by pharmaceutical negligence. More importantly, we’ll take on the legal process for you, investigating your case, gathering vital records, and holding those responsible accountable. That way, you can focus on your recovery while we focus on your justice. Contact our Depo-Provera lawyers at 917-540-8728 for a free case review.

FAQs

What Are the Signs of a Brain Tumor from Depo-Provera?

The most common signs include severe headaches, nausea, and vision problems. You may also notice seizures, personality changes, or memory loss. These symptoms develop because intracranial meningiomas linked to injectable Depo-Provera can press on areas of your brain that control vision, memory, and behavior. In some cases, these tumors grow slowly, and symptoms can be missed until they become more serious.

Where Are the Depo-Provera Lawsuits Consolidated?

Currently, all federal Depo-Provera lawsuits proceed through a Panel on Multidistrict Litigation (MDL) for coordinated management. This process groups similar cases under one judge. As a result, the MDL ensures consistent rulings and fair case management for claims involving the contraceptive injection and its severe side effects. It also helps avoid conflicting verdicts and ensures key evidence and expert testimony are used consistently across cases.

Has the Depo-Provera Lawsuit Reached Any Verdicts?

No, there have been no final verdicts in the current Depo-Provera lawsuits yet. Instead, the cases remain in early phases within the Depo-Provera MDL system. However, our Depo-Provera lawyers review medical evidence, FDA records, and studies related to meningioma risks, providing regular updates as the case moves forward

Can Depo-Provera Cause Other Types of Cancer?

Yes, limited research suggests long-term Depo-Provera injections may slightly raise certain cancer risks. Some studies link it to a small, temporary increase in breast cancer risk during active use. However, evidence for cervical or uterine cancer remains weak. These effects likely develop because Depot medroxyprogesterone acetate mainly targets progesterone receptors, which can indirectly affect hormone-sensitive tissues.

Can I Still File a Lawsuit If My Brain Tumor Was Diagnosed Years Ago?

Yes, you might still qualify depending on your state’s statute of limitations. This law controls how long you have to file a Depo-Provera lawsuit. But, in some cases, states allow extra time if you recently learned Depot medroxyprogesterone acetate caused your intracranial meningioma. However, it’s important to act quickly, as delays can still affect your Depo shot lawsuit eligibility and future Depo-Provera litigation rights.

How Do I Choose the Right Lawyer for a Depo-Provera Lawsuit?

Look for a lawyer experienced in pharmaceutical injury and multidistrict litigation cases. They should manage deadlines, gather medical records, and handle your MDL claim efficiently. Moreover, choose someone who has helped Depo-Provera patients in similar cases. They should also have experience filing lawsuits and successfully handling these claims from start to finish.

What Role Does the FDA Play in Depo-Provera Lawsuits?

The FDA oversees the safety of medications like Depot medroxyprogesterone acetate before and after approval. It reviews adverse event reports and can require updated warnings when new risks emerge. In many Depo-Provera meningioma lawsuits, plaintiffs argue the FDA acted too late or missed dangers like intracranial meningioma. Because of this, the FDA’s records and safety decisions often serve as key evidence to show what risks were known and when.

GET FREE CASE EVALUATION

Kyle Newman Founder and Senior Trial Lawyer at Uptown Injury Law New York's Best Personal Injury Medical Malpractice and Accident Law firm New York's Top Trial Lawyers
WRITTEN AND REVIEWED BY
Kyle Newman Founder and Senior Trial Lawyer at Uptown Injury Law New York's Best Personal Injury Medical Malpractice and Accident Law firm New York's Top Trial Lawyers

This content is trustworthy because it has been thoroughly researched, fact-checked and reviewed by experts in the field. The information provided is accurate and reliable, and sources have been cited to ensure transparency and credibility. The authors or publishers of this content have a reputation for producing high-quality, unbiased material. Additionally, any potential conflicts of interest or biases have been disclosed. Overall, readers can trust that the information presented in this content is trustworthy and credible.